Exchange: NYSE·Updated 04:03 AM EDT
DHR logo

DHR Danaher Corp.

$225.14
$0.65
(0.29%)
Pre-Market
Prev Close $224.49
EarningsOct 21
Mkt Cap$157.81B
Vol690.00

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
51

Neutral Sentiment

How do you feel about DHR?

Advertisement|Remove ads.